首页|血清asprosin、microRNA-20a-5p、miR-137在糖尿病性视网膜病变的水平变化及临床意义

血清asprosin、microRNA-20a-5p、miR-137在糖尿病性视网膜病变的水平变化及临床意义

扫码查看
目的:探讨血清asprosin、microRN A-20a-5p、miR-13 7在糖尿病性视网膜病变的水平变化及临床意义方法:选取2022。4-2024。4于医院收治的2型糖尿病患者(T2DM组)120例,并根据是否发生DR分为DR组60例,非DR组60例,在DR组内按照疾病的严重程度分为PDR40例以及NPDR20例,选取40例健康体检者为对照组,对比分析相关指标。结果:与对照组相比 asprosin、miR-137 在 T2DM 患者中均升高,miRNA-20a-5p 降低(P<0。05)。DR 组患者年龄、HbA1、FPG、LDL-C、asprosin、miR-137高于NDR组,病程长于NDR组,miR-20a-5p低于NDR组(P<0。05)。PDR组中病程、空腹血糖、糖化血红蛋白、asprosin和miR-137高于NPDR组,miR-20a-5p低于NPDR组(P<0。05)。病程、空腹血糖、糖化血红蛋白、asprosin和miR-137属于DR发生的独立危险因素,而miR-20a-5p为独立保护因素。结论:血清中asprosin、microRNA-20a-5p、miR-137的水平变化T2DM并发DR密切相关,可能成为DR防治的监测指标及靶点。
Level Changes and Clinical Significance of Serum Asprosin,microRNA-20a-5p,and miR-137 in Diabetic Retinopathy
Objective:To explore the changes and clinical significance of serum asprosin,microRNA-20a-5p,and miR-137 levels in diabetic retinopathy.Methods:120 patients(T2DM group)with type 2 DM were selected for 2022.4-20240 patients in DR group,60 patients in non-DR group,and 40 PDR and NPDR20 cases in DR group,40 healthy examination patients were selected as the control group,and relevant indicators were analyzed.Results:Compared with controls,asprosin and miR-137 were increased in T2DM patients,and miRNA-20a-5p was decreased(P<0.05).In the DR group,their age,HbA 1,FPG,LDL-C,asprosin,and miR-137 were higher than the NDR group,their disease duration was longer than the NDR group,and their miR-20a-5p was lower than the NDR group(P<0.05).In the PDR group,disease course,fasting glucose,hemoglobin A 1 c,asprosin and miR-137 were higher than that in the NPDR group,miR-20a-5p was lower than that in the NPDR group(P<0.05).Disease duration,fasting glucose,HbA 1 c,asprosin and miR-137 were independent risk factors for the development of DR,while miR-20a-5p was an independent protective factor.Conclusion:The levels of asprosin,microRNA-20a-5p and miR-137 in serum are closely related between T2DM and DR,which may become the monitoring index and target of DR prevention and treatment.

Type 2 diabetesDiabetic retinopathyAsprosinmiR-20a-5pmiR-137

王敏、孙志敏、周跃、顾文婷、孙杏红

展开 >

南通大学第二附属医院眼科 江苏南通 226000

南京医科大学附属苏州医院眼科 江苏苏州 215000

南京鼓楼医院眼科 江苏南京 210000

2型糖尿病 糖尿病性视网膜病变 asprosin 微RNA-20a-5p 微RNA-137

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(22)